It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Zika virus (ZIKV) is an emerging mosquito borne flavivirus and a major public health concern causing severe disease. Due to the presence of a lipid membrane and structural heterogeneity, attaining an atomic resolution structure is challenging, but important to understand virus assembly and life cycle mechanisms that offer distinct targets for therapeutic intervention. We here use subvolume refinement to achieve a 3.4 Å resolution structure and identify two distinct lipid moieties. The first arises from the inner leaflet and is coordinated by hydrophobic residues of the M and E transmembrane helices that form a binding pocket not previously characterized. The second lipid arises from the outer leaflet coordinate between two E protein helices. Structure-based mutagenesis identifies critical hydrophobic interactions and their effect on the virus life cycle. Results show that lipids play an essential role in the ZIKV assembly pathway revealing a potential target of lipid based antiviral drug development.
Here, the authors provide a 3.4 Å resolution structure of mature Zika virus (ZIKV) and identify two lipid moieties, coordinated by hydrophobic residues of the M and E transmembrane helices and between two helices of E protein, that play an essential role in the ZIKV assembly pathway.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 The Pennsylvania State University, Department of Biochemistry and Molecular Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University College of Medicine, Department of Medicine, Hershey, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
2 The Pennsylvania State University, Department of Biochemistry and Molecular Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
3 The Pennsylvania State University, The Huck Institutes of the Life Sciences, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
4 The Pennsylvania State University, Department of Biochemistry and Molecular Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University College of Medicine, Department of Medicine, Hershey, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University, The Huck Institutes of the Life Sciences, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
5 The Pennsylvania State University, Department of Biochemistry and Molecular Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University, The Huck Institutes of the Life Sciences, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)